TAUNS Laboratories
VC Fund
Shizuoka, Japan
TAUNS Laboratories is a Japanese company specialising in the development, manufacture, and sale of in vitro diagnostics and research reagents, focusing on rapid diagnostic test kits, particularly for infectious diseases such as tuberculosis, influenza, adenovirus, and norovirus.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries TAUNS Laboratories invests in
Stages TAUNS Laboratories invests in
Countries TAUNS Laboratories invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Masaki Nonaka
|
|||
Investment Focus
Industry
- Artificial Intelligence 2 (100%)
- Medical 1 (50%)
- Oncology 1 (50%)
- Analytics 1 (50%)
- Health Care 1 (50%)
Stage
- Series B 1 (50%)
- Series D 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Masaki Nonaka
CEO & President
|
CEO & President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Craif
|
Icaria's mission is to create a new society in which people will not lose their lives by using urine tests to provide "early, painless and accurate early diagnosis of cancer."It is known that detecting cancer early increases the survival rate 5 to 10 times and greatly improves the prognosis. However, it is not unusual for manycancers to have no subjective symptoms, and when they become aware they have progressed to a stage where treatment is impossible. The most effective way to detect cancer at an early stage that can be treated is to have regular and high-precision cancer diagnosis, but existing cancer diagnosis is painful and However, many of them are not accurate enough and are not suitable for regular diagnosis and early stage diagnosis. | $24.4M / Series D / Aug 18, 2026 | |
EMC Healthcare
|
EMC Healthcare is a healthcare technology company that provides sensors, nurse calls, and camera security using AI, analytics, and IoT. | Series B / Jan 14, 2026 |
Co-Investors
Granite-Integral
1 deal together
Hokkaido Co-Creation Partners
1 deal together
Kodomo no Mori
1 deal together
Unreasonable
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does TAUNS Laboratories invest in?
TAUNS Laboratories invests primarily in Artificial Intelligence, Medical and Oncology startups, most often at Series B and Series D stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact TAUNS Laboratories?
Public channels for TAUNS Laboratories include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TAUNS Laboratories?
The team at TAUNS Laboratories includes Masaki Nonaka (CEO & President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
